Mayaro virus pathogenesis and immunity in rhesus macaques

Whitney C Weber1,2, Caralyn S Labriola1,3, Craig N Kreklywich1

  • 1Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

PubMed

Insights

Mayaro virus (MAYV) causes severe joint disease. This study used rhesus macaques to model MAYV infection, revealing viral spread, immune responses, and potential for vaccine development against this emerging alphavirus.

Area of Science:

  • Virology
  • Immunology
  • Pathogenesis

Background:

  • Mayaro virus (MAYV) is a mosquito-borne alphavirus causing persistent arthritogenic disease.
  • Understanding MAYV pathogenesis in non-human primates (NHP) is crucial for developing effective interventions.

Purpose of the Study:

  • To characterize MAYV infection and immune responses in a rhesus macaque model.
  • To establish a relevant NHP model for evaluating MAYV therapies and vaccines.

Main Methods:

  • Evaluated five MAYV strains in mice to select a virulent strain (BeAr505411).
  • Inoculated three rhesus macaques with MAYV strain BeAr505411.
  • Assessed viral dissemination, tissue pathology, and immune activation via necropsy and longitudinal blood sampling.

Main Results:

  • Peak viremia occurred at 2 days post-infection (dpi), with viral RNA detected in muscles, joints, and various organs up to 10 dpi.
  • Histopathology revealed joint and muscle inflammation, with skin lesions and lymphocytic aggregation in affected skin.
  • Robust innate and adaptive immune activation, including neutralizing antibodies and elevated inflammatory cytokines, was observed.

Conclusions:

  • The rhesus macaque model effectively recapitulates key aspects of human MAYV infection.
  • This model provides a valuable platform for preclinical testing of novel MAYV vaccines and therapeutics.
  • Findings highlight the potential for MAYV to cause widespread tissue dissemination and significant immune responses.

Related Concept Videos